- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05867394
The Effect of Stress Ball Application Before Coronary Angiography on Stress, Anxiety and Vital Signs
May 19, 2023 updated by: Aysel Sesci
It aimed to examine stress, anxiety and resorting to life paths to enable researchers to contain this stress.
Study Overview
Detailed Description
Stress and anxiety lives of patients before coronary angiography.
The stress and anxiety they experience also affect their vital signs.
The researchers aimed to examine the ways the stress ball affected their patients' stress, anxiety, and vital signs.
Study Type
Interventional
Enrollment (Anticipated)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aysel SESCİ
- Phone Number: 0382288 2903
- Email: aysel.sesci70@icloud.com
Study Contact Backup
- Name: Kadriye SAYIN KASAR
- Phone Number: 0382288 2785
- Email: kadriyekasar@aksaray.edu.tr
Study Locations
-
-
University
-
Aksaray, University, Turkey, 68000
- Recruiting
- Aysel SESCİ
-
Contact:
- Aysel SESCİ
- Phone Number: 03822882903
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 18 years and over
- For those who will undergo coronary angiography for the first time
- Able to read and write
- Not diagnosed with anxiety disorder and not using medication for it
- No physical disability to use the stress ball
- Cognitive health levels consist of individuals who are suitable for answering data collection forms.
Exclusion Criteria:
- Unconscious and not fully oriented
- Sight and hearing problems
- Alzheimer's disease and other types of dementia
- Having a severe psychiatric problem that cannot answer the questions
- Those who came with MI (myocardial infarction) and performed CAG
- Individuals who are closed to communicating are not included in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Stress ball
Data were collected by the investigator 25-30 minutes before coronary angiography and the first measurement of vital signs was made.
After the stress ball application, State Anxiety Inventory data were collected for the second time and the second measurement of vital signs was made.
Vital signs were measured and noted for the third time after coronary angiography.
|
Stress ball squeeze
|
No Intervention: Control
25-30 minutes before the coronary angiography procedure, data were collected from the patients by the investigator and the first measurements of their vital signs were recorded.
Vital signs were measured a second time just before coronary angiography without any intervention.
Vital signs were measured and recorded for the third time after coronary angiography ischemia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
State Anxiety Score
Time Frame: Change in state anxiety score within one day
|
Scale measuring patients' anxiety.
The scores obtained from the scale vary between 20 and 80.
A large score indicates high anxiety, and a small score indicates low anxiety.
|
Change in state anxiety score within one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Distress Thermometer
Time Frame: Only on day 1, 2 times a day (same day).
|
It is a scale that measures the patient's stress level.
The scale is scored between 0 and 10 points.
A score of 0 indicates no stress, and a score of 10 indicates extreme stress.
|
Only on day 1, 2 times a day (same day).
|
Systolic Blood Pressure Value (mmHg)
Time Frame: Only on day 1, 2 times a day (same day).
|
The effect of the intervention on systolic blood pressure is examined.
|
Only on day 1, 2 times a day (same day).
|
Diastolic Blood Pressure Value (mmHg)
Time Frame: It will be measured 3 times a day (same day) on day 1 only.
|
The effect of the intervention on diastolic blood pressure is examined.
|
It will be measured 3 times a day (same day) on day 1 only.
|
Heart Rate/Minute Value
Time Frame: It will be measured 3 times a day (same day) on day 1 only.
|
The effect of the intervention on the heart rate is examined.
|
It will be measured 3 times a day (same day) on day 1 only.
|
Respiratory Rate/Minute Value
Time Frame: It will be measured 3 times a day (same day) on day 1 only.
|
The effect of the intervention on the respiratory rate is examined.
|
It will be measured 3 times a day (same day) on day 1 only.
|
Peripheral Oxygen Saturation (SpO2) Value
Time Frame: It will be measured 3 times a day (same day) on day 1 only.
|
The effect of the intervention on peripheral oxygen saturation is examined.
|
It will be measured 3 times a day (same day) on day 1 only.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2022
Primary Completion (Anticipated)
May 30, 2023
Study Completion (Anticipated)
June 1, 2023
Study Registration Dates
First Submitted
February 28, 2023
First Submitted That Met QC Criteria
May 19, 2023
First Posted (Actual)
May 22, 2023
Study Record Updates
Last Update Posted (Actual)
May 22, 2023
Last Update Submitted That Met QC Criteria
May 19, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Aksaray Üniversitesi
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Study protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
San Luigi Gonzaga HospitalRecruitingCoronary Disease | STEMI | Coronary Artery Ectasia | Right Coronary Artery Occlusion | Right Coronary Artery StenosisSpain, Italy
Clinical Trials on Stress ball
-
Bedriye Cansu DEMİRKIRANCompletedDepression | Quality of Life | Irritable Bowel Syndrome | Stress | AnxietyTurkey
-
Kırklareli UniversityCompletedAnxiety | Pregnancy RelatedTurkey
-
TC Erciyes UniversityCompleted
-
Kirsehir Ahi Evran UniversitesiRecruitingInhalation Therapy; ComplicationsTurkey
-
Saglik Bilimleri UniversitesiRecruiting
-
Ayse Sonay Turkmen, Assoc. ProfCompleted
-
Akdeniz UniversityNot yet recruitingStress | Cholecystitis | Fear | Comfort
-
Atlas UniversityRecruitingNeurologic DisorderTurkey
-
Ondokuz Mayıs UniversityNot yet recruitingPain | Anxiety State | Exanimation
-
Keriman YildizNecmettin Erbakan UniversityCompletedAnxiety | Percutaneous Coronary Intervention | HemodynamicsTurkey